Ovid Therapeutics Inc. announced that Dr. Yaron Werber, M.D., chief business and financial officer, will leave the company effective September 21, 2018. Dr. Werber joined Ovid as chief financial officer in June 2015 after nearly 15 years of experience as a highly-ranked biotechnology research analyst at marquee Wall Street firms. Dr. Werber will return to Wall Street as managing director and senior biotechnology analyst at Cowen and Company.